Explore peptide ingredients, related compounds, and preparation information in one place. Review product-specific details and eligibility before moving forward through your approved clinic account.
Public ingredient information · Eligible ordering for approved clinic accounts
Start with a product family, then review the preparation names and their individual requirements.
Several ingredients in this directory are investigational or lack sufficient human safety information. Reference listings are not offers to supply them. Approval, route, compounding requirements, and current pharmacy eligibility must be reviewed for the exact product.
Understand peptide product review →
Ingredient informationSermorelin, tesamorelin, CJC-1295, ipamorelin, and related names. Review each ingredient and formulation separately.
View preparation names →A listing does not establish approval or ordering eligibility.
Ingredient informationSingle ingredients and combinations, presented for identification and regulatory review.
View preparation names →A listing does not establish approval or ordering eligibility.
Ingredient informationIngredient listings include different formulations and routes. Product-specific status matters.
View preparation names →A listing does not establish approval or ordering eligibility.
Ingredient informationExplore individual ingredient names and combinations alongside our Sexual Health category.
View preparation names →A listing does not establish approval or ordering eligibility.
Ingredient informationReference information for ingredient identification. Catalog placement does not establish a clinical indication.
View preparation names →A listing does not establish approval or ordering eligibility.
Ingredient informationIncludes MOTS-C, SS-31, thymosin-related names, and other preparations requiring individual review.
View preparation names →A listing does not establish approval or ordering eligibility.
Images are illustrative and do not depict actual product packaging. No medical benefits, indications, or treatment outcomes are established by this directory.
Open a family to view its listed preparation names. Some names require clarification; no listed specification should be treated as a verified product label or dosing instruction.
Sermorelin, tesamorelin, CJC-1295, ipamorelin, and related names. Review each ingredient and formulation separately.
Reference names only. Numerical values may describe concentration or package content; they are not dosing directions. Confirm identity, route, specification, and regulatory eligibility with the responsible pharmacy.
Single ingredients and combinations, presented for identification and regulatory review.
Reference names only. Numerical values may describe concentration or package content; they are not dosing directions. Confirm identity, route, specification, and regulatory eligibility with the responsible pharmacy.
Ingredient listings include different formulations and routes. Product-specific status matters.
Reference names only. Numerical values may describe concentration or package content; they are not dosing directions. Confirm identity, route, specification, and regulatory eligibility with the responsible pharmacy.
Explore individual ingredient names and combinations alongside our Sexual Health category.
Reference names only. Numerical values may describe concentration or package content; they are not dosing directions. Confirm identity, route, specification, and regulatory eligibility with the responsible pharmacy.
Reference information for ingredient identification. Catalog placement does not establish a clinical indication.
Reference names only. Numerical values may describe concentration or package content; they are not dosing directions. Confirm identity, route, specification, and regulatory eligibility with the responsible pharmacy.
Includes MOTS-C, SS-31, thymosin-related names, and other preparations requiring individual review.
Reference names only. Numerical values may describe concentration or package content; they are not dosing directions. Confirm identity, route, specification, and regulatory eligibility with the responsible pharmacy.
Review every ingredient in a blend; a blend name does not confirm its composition or availability.
Reference names only. Numerical values may describe concentration or package content; they are not dosing directions. Confirm identity, route, specification, and regulatory eligibility with the responsible pharmacy.
NAD+ is a related compound, not a peptide. Also explore these preparations in Wellness & Nutrition.
Reference names only. Numerical values may describe concentration or package content; they are not dosing directions. Confirm identity, route, specification, and regulatory eligibility with the responsible pharmacy.
Some listed names contain abbreviations, inconsistent spelling, or incomplete composition. Identity must be resolved before product review.
Reference names only. Numerical values may describe concentration or package content; they are not dosing directions. Confirm identity, route, specification, and regulatory eligibility with the responsible pharmacy.
Connect product information with your account workflow while keeping clinical and pharmacy decisions with the responsible professionals.
Identify the ingredient and exact preparation.
Confirm status, pharmacy eligibility, and product details.
Order eligible products through your approved account.
Qualified clinics reviewing ingredient and preparation information. This public page does not offer patient checkout or provide treatment recommendations.
No. This directory includes investigational, unverified, and incompletely specified preparations. Their names are retained for reference only. A public listing does not establish lawful availability, current stock, or pharmacy eligibility.
No. NAD+, methylene blue, MK-677, SLU-PP-332, and other related compounds appear in separate groups. Category placement does not change an ingredient’s classification.
No. Review the exact finished product, formulation, route, and regulatory status. An ingredient name or similar brand-name medicine does not establish approval of a different preparation.
Confirm each ingredient, the complete formulation, concentration, route, and package information. Named blends and abbreviations should not be treated as verified specifications.
After account approval, review the exact product’s current pharmacy information and eligibility. Order only products that meet applicable requirements and pharmacy review; research or unresolved listings are not ordering options on this public page.
Understand ingredient identity, product status, and preparation-specific questions.
Read the guide →
Recognize why research status requires a separate review.
Read the guide →
Learn which formulation and package details to confirm.
Read the guide →FDA identifies potential safety risks and limited human data for several substances listed in this category. Status varies by ingredient, route, and compounding framework. A withdrawn nomination is not FDA approval. Compounded preparations are not FDA-approved. This page provides ingredient reference information, not treatment selection, dosing, or administration instructions.
Sources checked October 6, 2026. CoreLink provides platform access and nonclinical coordination; it does not prescribe, dispense, or provide medical advice.
Begin account review to explore eligible pharmacy products and ordering options.